Vincent Anzalone
Senior Vice President, Investor Relations
Replay available
Arrowhead Pharmaceuticals, Inc. (ARWR) Q3 2026 Earnings Call
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) Q3 2026 earnings conference call, held 2026-08-04. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Chris Anzalone
President and Chief Executive Officer
Andy Davis
Senior Vice President and Head of the Global Cardio‐Vetabolic Franchise
Dr. James Hamilton
Chief Medical Officer and Head of R&D
Dan Apel
Chief Financial Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Arrowhead Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a041be-8788-7c92-a2b1-a19e09be1d52 Created: 2026-08-27T05:43:22.789Z Duration: 3413.2375 Channels: 1 00:00:00.000 -- 00:00:00.880 Welcome 00:00:00.880 -- 00:00:02.639 to the Arrowhead Pharmaceuticals 00:00:02.639 -- 00:00:03.840 Conference Call. 00:00:04.160 -- 00:00:06.480 Throughout today's recorded presentation, 00:00:06.720 -- 00:00:09.280 all participants will be in a listen mode 00:00:09.280 -- 00:00:09.999 only. 00:00:10.400 -- 00:00:11.839 After the presentation, 00:00:11.920 -- 00:00:14.480 there will be an opportunity to ask questions. 00:00:15.275 -- 00:00:18.075 I will now hand the conference over to 00:00:18.075 -- 00:00:19.755 Vincent Anzalone, 00:00:20.635 -- 00:00:24.395 Senior Vice President of Investor Relations for Arrowhead. 00:00:24.395 -- 00:00:25.675 Please go ahead, Vince. 00:00:27.880 -- 00:00:30.200 Thank you, and good afternoon, everyone. Thank you 00:00:30.200 -- 00:00:32.680 for joining us today to discuss Arrowhead's results 00:00:32.680 -- 00:00:35.400 for its fiscal twenty twenty six third quarter 00:00:35.400 -- 00:00:37.879 ended 06/30/2026. 00:00:38.120 -- 00:00:40.440 With us today from management are President and 00:00:40.440 -- 00:00:42.040 CEO, Doctor. Chris Anzalone, 00:00:42.395 -- 00:00:43.914 who will provide an overview 00:00:44.074 -- 00:00:46.315 Andy Davis, Senior Vice President and Head of 00:00:46.315 -- 00:00:47.594 the Global CardioVentabolic 00:00:47.594 -- 00:00:48.394 Franchise, 00:00:48.555 -- 00:00:51.434 who will provide an update on commercialization activities 00:00:51.594 -- 00:00:54.235 Doctor. James Hamilton, Chief Medical Officer and Head 00:00:54.235 -- 00:00:55.980 of R and D, who will discuss our 00:00:55.980 -- 00:00:57.260 development prog...